Collections
DOJ Antitrust Division Business Review Letters
2021
21-1
Baxalta, Emergent BioSolutions, Grifols Therapeutics, and CSL Plasma
Antitrust Division, U.S. Department of Justice
Learn More
Log In
Sign Up
21-1
Expedited Business Review Letter (January 12, 2021)
21-1
Request Letter: Baxalta, Emergent BioSolutions, Grifols Therapeutics, and CSL Plasma (January 5, 2021)